Literature DB >> 16260046

Historical review: Negative efficacy and the constitutive activity of G-protein-coupled receptors.

Tommaso Costa1, Susanna Cotecchia.   

Abstract

The idea that a receptor can produce signalling without agonist intervention and that several antagonists can be 'active' in repressing such spontaneous activity is contained in the concept of ligand-induced conformational changes. Yet, this idea was neglected by pharmacologists for many years. In this article, we review the events that brought inverse agonism and constitutive activity to general attention and made this phenomenon a topic of current research. We also suggest a classification of antagonists based on the cooperativity that links their primary site of interaction with other functional domains of the receptor.

Mesh:

Substances:

Year:  2005        PMID: 16260046     DOI: 10.1016/j.tips.2005.10.009

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  31 in total

Review 1.  The significance of G protein-coupled receptor crystallography for drug discovery.

Authors:  John A Salon; David T Lodowski; Krzysztof Palczewski
Journal:  Pharmacol Rev       Date:  2011-12       Impact factor: 25.468

2.  Superactive mutants of thromboxane prostanoid receptor: functional and computational analysis of an active form alternative to constitutively active mutants.

Authors:  Manuela Ambrosio; Francesca Fanelli; Silvia Brocchetti; Francesco Raimondi; Mario Mauri; G Enrico Rovati; Valérie Capra
Journal:  Cell Mol Life Sci       Date:  2010-04-11       Impact factor: 9.261

Review 3.  Ensemble of G protein-coupled receptor active states.

Authors:  P S-H Park
Journal:  Curr Med Chem       Date:  2012       Impact factor: 4.530

4.  Cholinergic interneurons control the excitatory input to the striatum.

Authors:  Pavel Pakhotin; Enrico Bracci
Journal:  J Neurosci       Date:  2007-01-10       Impact factor: 6.167

Review 5.  G-protein-coupled receptor heteromers: function and ligand pharmacology.

Authors:  R Franco; V Casadó; A Cortés; J Mallol; F Ciruela; S Ferré; C Lluis; E I Canela
Journal:  Br J Pharmacol       Date:  2007-11-26       Impact factor: 8.739

Review 6.  Embracing emerging paradigms of G protein-coupled receptor agonism and signaling to address airway smooth muscle pathobiology in asthma.

Authors:  Raymond B Penn
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-02-16       Impact factor: 3.000

7.  Constitutive somatostatin receptor activity determines tonic pituitary cell response.

Authors:  Anat Ben-Shlomo; Cuiqi Zhou; Oxana Pichurin; Vera Chesnokova; Ning-Ai Liu; Michael D Culler; Shlomo Melmed
Journal:  Mol Endocrinol       Date:  2009-01-08

8.  Ligands raise the constraint that limits constitutive activation in G protein-coupled opioid receptors.

Authors:  Vanessa Vezzi; H Ongun Onaran; Paola Molinari; Remo Guerrini; Gianfranco Balboni; Girolamo Calò; Tommaso Costa
Journal:  J Biol Chem       Date:  2013-07-08       Impact factor: 5.157

Review 9.  Constitutive activation of G protein-coupled receptors and diseases: insights into mechanisms of activation and therapeutics.

Authors:  Ya-Xiong Tao
Journal:  Pharmacol Ther       Date:  2008-08-09       Impact factor: 12.310

Review 10.  Regulation of μ-opioid receptors: desensitization, phosphorylation, internalization, and tolerance.

Authors:  John T Williams; Susan L Ingram; Graeme Henderson; Charles Chavkin; Mark von Zastrow; Stefan Schulz; Thomas Koch; Christopher J Evans; Macdonald J Christie
Journal:  Pharmacol Rev       Date:  2013-01-15       Impact factor: 25.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.